Cargando…

What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?

BACKGROUND: Mass drug administration (MDA) of ivermectin for onchocerciasis has been disrupted by the coronavirus disease 2019 (COVID-19) pandemic. Mathematical modelling can help predict how missed/delayed MDA will affect short-term epidemiological trends and elimination prospects by 2030. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamley, Jonathan I D, Blok, David J, Walker, Martin, Milton, Philip, Hopkins, Adrian D, Hamill, Louise C, Downs, Philip, de Vlas, Sake J, Stolk, Wilma A, Basáñez, Maria-Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928565/ https://www.ncbi.nlm.nih.gov/pubmed/33515042 http://dx.doi.org/10.1093/trstmh/traa193

Ejemplares similares

Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring
por: Hamley, Jonathan I D, et al.
Publicado: (2020)

Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making
por: Stolk, Wilma A, et al.
Publicado: (2021)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs
por: Hamley, Jonathan I. D., et al.
Publicado: (2019)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

Advancing a standardised approach to onchocerciasis elimination mapping
por: Hamill, Louise, et al.
Publicado: (2019)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
por: Hamill, Louise, et al.
Publicado: (2022)

Feasibility of Onchocerciasis Elimination Using a “Test-and-not-treat” Strategy in Loa loa Co-endemic Areas
por: Blok, David J, et al.
Publicado: (2020)

Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium
por: Behrend, Matthew R., et al.
Publicado: (2020)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
por: Kura, Klodeta, et al.
Publicado: (2023)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal
por: Walker, Martin, et al.
Publicado: (2017)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

Onchocerciasis: The Pre-control Association between Prevalence of Palpable Nodules and Skin Microfilariae
por: Coffeng, Luc E., et al.
Publicado: (2013)

Demographic patterns of human antibody levels to Simulium damnosum s.l. saliva in onchocerciasis-endemic areas: An indicator of exposure to vector bites
por: Willen, Laura, et al.
Publicado: (2022)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
por: Stolk, Wilma A, et al.
Publicado: (2006)

Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa
por: Kim, Young Eun, et al.
Publicado: (2017)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2022)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)

Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2023)

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results
por: Tekle, Afework H., et al.
Publicado: (2016)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Global elimination of leprosy by 2020: are we
por: Blok, David J., et al.
Publicado: (2015)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

Report of the first international workshop on onchocerciasis-associated epilepsy
por: Colebunders, Robert, et al.
Publicado: (2018)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Onchocerciasis in the Americas: from arrival to (near) elimination
por: Gustavsen, Ken, et al.
Publicado: (2011)

The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
por: Turner, Hugo C, et al.
Publicado: (2015)

Designing antifilarial drug trials using clinical trial simulators
por: Walker, Martin, et al.
Publicado: (2020)

African Programme for Onchocerciasis Control 1995–2015: Model-Estimated Health Impact and Cost
por: Coffeng, Luc E., et al.
Publicado: (2013)

Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali
por: Dolo, Housseini, et al.
Publicado: (2020)

Corrigendum to: Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
Publicado: (2022)

Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
por: Michael, Edwin, et al.
Publicado: (2018)

African Programme for Onchocerciasis Control 1995–2015: Updated Health Impact Estimates Based on New Disability Weights
por: Coffeng, Luc E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c80ateg0gqqieorchjkubqk6fd